Lipella Pharmaceuticals Inc (LIPO): Narxning daromadga nisbati

Lipella (LIPO) brendining ramzi va logotipi

Lipella Pharmaceuticals faoliyati AQSh qoidalari bilan himoyalangan, bu esa savdo mojarolari xavfini minimallashtiradi. Kompaniya patent himoyasidan foydalangan holda genitouriya tizimi patologiyalari uchun og'iz orqali davolash usullarini ishlab chiqmoqda. ESG standartlarini joriy etish va chiqindilarni tozalash laboratoriya faoliyatini optimallashtiradi. P/S vaqt qatorlari daromad bozor qiymatining qarz bilan o'zaro bog'liqligini aniqlashga imkon beradi, 7.30 esa ushbu metrikaning joriy hajmini ko'rsatadi.

Lipella Pharma (LIPO): Narxning daromadga nisbati 28.04.2023dan 19.07.2025gacha

Lipella (LIPO) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi lipella.com|LIPO - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor qiymati Lipella|LIPO - Korxona qiymati
- emitentning balans qiymati statistikasi:
Aksiya hisobiga sof aktivlar Lipella Pharmaceuticals|LIPO - Kompaniyaning balans qiymati|Sof aktivlarga nisbatan bozor kapitallashuvi lipella.com|LIPO - Kompaniyaning umumiy aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Lipella Pharmaceuticals|LIPO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Lipella Pharma|LIPO - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Lipella|LIPO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Lipella Pharmaceuticals|Oraliq qoplash koeffitsiyenti lipella.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
LIPO - Kompaniyaning sof foydasi|Forvard foyda Lipella Pharmaceuticals|LIPO - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori Lipella Pharmaceuticals Inc|LIPO - PEG multiplikatori|EV/EBITDA multiplikatori Lipella|LIPO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Lipella Pharmaceuticals|LIPO - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi lipella.com|LIPO - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Lipella Pharmaceuticals
- umumiy tushum va sotuv hajmi ma'lumotlari:
LIPO - Daromad va sotish hajmi|Kompaniyaning kelajakdagi sotish hajmi lipella.com|LIPO - P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Lipella
Kompaniyaning fundamental tahlili:lipella.com LIPO
Lipella Pharma seriyali mahsuloti

P/S koeffitsiyenti biznesning bozor qiymatini uning yillik aylanmasiga nisbatan belgilaydi va daromadning har bir birligi uchun to'langan premiumni baholash imkonini beradi. O'z ishlab chiqarishi va tadqiqotlarini to'liq tashqi pudratchilarga topshirgan Lipella Pharmaceuticals (LIPO) uchun ushbu ko'rsatkich juda muhimdir, chunki joriy P/S dinamikasi ichki imkoniyatlar yo'qligida kapitalizatsiya va haqiqiy savdolar o'rtasidagi spekulyativ tafovutni ochib beradi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue KVUE|Verona Pharma PLC - Narxning daromadga nisbati|Jyong Biotech Corp - P/S multiplikatori|Narx/daromad koeffitsiyenti Ligand Corp LGND|Amneal Pharmaceuticals (AMRX) - Narxning daromadga nisbati|Narxning sotuvga nisbati PRGO (perrigo.com)|ALVO (Alvotech SA) - P/S multiplikatori|Sotuvga nisbatan narx Liquidia Corp LQDA|Narxning daromadga nisbati Galapagos Genomics (GLPG)|Narxning daromadga nisbati ANIP (ANI Pharmaceuticals Corp)|Narxning daromadga nisbati MannKind Corporation MNKD|amphastar.com - Narxning daromadga nisbati|Pacira BioSciences, Inc. - P/S multiplikatori|SPRY - P/S multiplikatori|TBPH (Theravance) - Kapitalizatsiyaning daromadga nisbati|Aquestive Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati scPharmaceuticals, Inc.|Tectonic - Narxning sotuvga nisbati|P/S multiplikatori TNXP|SXTC (sxtchina.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals Inc.)|P/S multiplikatori BioHarvest Sciences Inc BHST|EXOZ - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ORMP (Oramed Pharmaceuticals)|enterabio.com (ENTX) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - P/S multiplikatori|P/S multiplikatori Cumberland Corp|P/S multiplikatori QNTM|Kapitalizatsiyaning daromadga nisbati fibrogen.com FGEN|P/S multiplikatori TELO (Telomir Pharmaceuticals, Inc.)|Rani Therapeutics Holdings (RANI) - Sotuvga nisbatan narx|SNYR: Kapitalizatsiyaning daromadga nisbati|RLYB - P/S multiplikatori|LEXX (lexariabioscience.com) - Kapitalizatsiyaning daromadga nisbati|PULM: Kapitalizatsiyaning sotish hajmiga nisbati|PTHL (Pheton Holdings Limited) - P/S multiplikatori|Aptorum (APM) - Narx/daromad koeffitsiyenti|P/S multiplikatori LYRA|Kapitalizatsiyaning daromadga nisbati Impact BioMedical, Inc. IBO|P/S multiplikatori TNFA (TNF Pharmaceuticals, Inc.)|P/S multiplikatori cbdMD Inc. YCBD|PRFX - Narxning daromadga nisbati|CYTO: Narxning daromadga nisbati|Optinose (OPTN) - Narxning daromadga nisbati|PIRS - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Procaps Group S.A.|Narxning daromadga nisbati PTPI|P/S multiplikatori QLI|Narx/daromad koeffitsiyenti Acelyrin Inc.|Narxning daromadga nisbati TFF Pharma TFFP